Aberrant astrocyte Ca2+ signals "AxCa signals" exacerbate pathological alterations in an Alexander disease model

Glia. 2018 May;66(5):1053-1067. doi: 10.1002/glia.23300. Epub 2018 Jan 31.

Abstract

Alexander disease (AxD) is a rare neurodegenerative disorder caused by gain of function mutations in the glial fibrillary acidic protein (GFAP) gene. Accumulation of GFAP proteins and formation of Rosenthal fibers (RFs) in astrocytes are hallmarks of AxD. However, malfunction of astrocytes in the AxD brain is poorly understood. Here, we show aberrant Ca2+ responses in astrocytes as playing a causative role in AxD. Transcriptome analysis of astrocytes from a model of AxD showed age-dependent upregulation of GFAP, several markers for neurotoxic reactive astrocytes, and downregulation of Ca2+ homeostasis molecules. In situ AxD model astrocytes produced aberrant extra-large Ca2+ signals "AxCa signals", which increased with age, correlated with GFAP upregulation, and were dependent on stored Ca2+ . Inhibition of AxCa signals by deletion of inositol 1,4,5-trisphosphate type 2 receptors (IP3R2) ameliorated AxD pathogenesis. Taken together, AxCa signals in the model astrocytes would contribute to AxD pathogenesis.

Keywords: Alexander disease; AxCa signals; GFAP; IP3R2; astrocyte.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / metabolism
  • Aging / pathology
  • Alexander Disease / metabolism*
  • Alexander Disease / pathology
  • Animals
  • Astrocytes / metabolism*
  • Astrocytes / pathology
  • Calcium / metabolism*
  • Calcium Signaling / physiology*
  • Cations, Divalent / metabolism
  • Disease Models, Animal
  • Glial Fibrillary Acidic Protein / genetics
  • Glial Fibrillary Acidic Protein / metabolism
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Humans
  • Male
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • RNA, Messenger / metabolism
  • Transcriptome

Substances

  • Cations, Divalent
  • Glial Fibrillary Acidic Protein
  • RNA, Messenger
  • Calcium